openPR Logo

Press Releases from ONY, Inc. (2 total)

Respiratory Distress in Premature Infants

FOR IMMEDIATE RELEASE New York, NY:Respiratory distress syndrome (RDS) is a breathing condition common in premature infants whose lungs have not fully developed yet. The earlier the birth in gestational time, the more prone the infant is to RDS and the more severe it is likely to be. Fully developed lungs are coated with a naturally occurring slippery substance called surfactant. Surfactant lines the air sacs in the lungs and reduces surface

Survanta in the Treatment of RDS in NICU Patients

FOR IMMEDIATE RELEASE New York, U.S:Survanta (Beractant) is widely used in the treatment of respiratory distress syndrome (RDS) in premature infants. Made from animal lung protein, Survanta keeps the lungs from collapsing by reducing the surface tension of fluids inside the lungs. Introduced in 1991, Survanta has treated more than 800,000 infants, with more than one million doses administered. RDS is most common in premature infants who are born approximately six weeks

Go To Page:   1 2 3 4 5 6 7 8 9 10